Proyectos de ley › 88.ª Asamblea General

HF 2141Murió al terminar la sesión · 6 de febrero de 2020

Relating to information to be provided by the department of public health regarding vaccines and information distributed through the Iowa immunization program

Temas:Health care

Dónde está ahora

  1. Hecho: Presentado28 de enero de 2020
  2. Hecho: Subcomité28 de enero de 2020
  3. Se detuvo: Comité de la CámaraMurió al terminar la Asamblea General
  4. Sigue: Lo aprueba la Cámara
  5. Sigue: Comité del Senado
  6. Sigue: Lo aprueba el Senado
  7. Sigue: A gobernador(a)
  8. Sigue: Firmado como ley

Murió al terminar la sesión La sesión de 2020 terminó el 14 de junio de 2020, la última sesión ordinaria de la Asamblea General. Los proyectos que no pasaron por ambas cámaras murieron. ¿Qué es el embudo (funnel)?

Qué contiene

Resumen con IA The Iowa Department of Public Health would be required to include specific information when giving out vaccines and related materials. This information must explain that vaccine manufacturers are protected from certain legal lawsuits and must list the ingredients used in the vaccines. It also requires a statement about the risks of certain ingredients used to help the vaccine work better. (Todavía no está traducido al español.)1

Lea la explicación oficial (en inglés)

This bill relates to the Iowa immunization program under the purview of the department of public health (DPH) that includes the activities funded by the federal vaccines for children program. The bill requires DPH to require that vaccines and information distributed through the Iowa immunization program include certain information. §300aa-22, relating to the standards of responsibility for manufacturers of vaccines that provide that a manufacturer is immune from liability in a civil action for damages arising from a vaccine-related injury or death associated with the administration of a vaccine after October 1, 1988, if the injury or death resulted from side effects that were unavoidable even though the vaccine was properly prepared and was accompanied by proper directions and warnings, or solely due to the manufacturer’s failure to provide direct warnings to the injured party (or the injured party’s legal representative) of the potential dangers resulting from the administration of the vaccine manufactured by the manufacturer; a statement explaining the law in plain language regarding the limitation of liability of a manufacturer of a vaccine, including the excipients added to the vaccine; the centers for disease control and prevention of the United States department of health and human services vaccine excipient summary for the specific vaccine type and, unless information is available to the contrary, a statement that the adjuvants in the vaccine have inherent, unavoidable risks and have not been scientifically evaluated for long-term adverse events or against the adjuvants of any other vaccine. An excipient is an ingredient contained in a vaccine in addition to weakened or killed disease antigens. An adjuvant is an excipient that is added to the vaccine to help stimulate a stronger immune response and includes aluminum salts.

Texto completo del proyecto (en inglés)2

House subcommittee

Named January 28, 2020. On February 6, 2020 it recommended indefinite postponement.

Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part

Cabildeo

3 a favor · 7 en contra · 12 indecisos · Quiénes →